HelloBetter develops digital programmes for mental health, which patients receive on prescription. Several of its programmes have been approved by the German Federal Institute for Drugs and Medical Devices (BfArM) as digital health applications, known as DiGA, and cover conditions such as depression, stress, panic and anxiety, problematic alcohol use, sleep problems and vaginismus.
HelloBetter is a German company headquartered in Germany; the sources consulted name Berlin or Hamburg as the city. Its funding comes from several investors, including a 2025 round led by Mutuelles Impact, a fund managed by XAnge, and no single majority owner was identified in the sources consulted. The public materials reviewed do not state where patient data is hosted, so a European organisation should check the provider's privacy and processing documents before use. The programmes are not described as open-source software. As a German provider, HelloBetter is subject to the GDPR.